Список литературы

Поставить закладку

Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis 2011;203:1021-30.
Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009;5(1):e1000319.
Khor CC, Davila S, Shimizu C, et al. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet 2011;48(7):467472.
Mamtani M, Matsubara T, Shimizu C, et al. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS ONE 2010;7;5(7):e11458.
Onouchi Y. Susceptibility genes for Kawasaki disease. Nihon Rinsho. Sep 2014;72(9):15541560.
Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol 2010;20:302-307
http://www.cdc.gov/kawasaki/
Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123(3):e401-405
Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J 2009; 28(1):21-24.
Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадочные синдромы у детей. рекомендации по диагностике и лечению. М. Союз педиатров России;2011: 208с.
Лыскина Г.А., Ширинская О.Г. Слизисто-кожный лимфонодулярный синдром (синдром Кавасаки). Диагностика и лечение. ВИДАР, М. 2008. 140 с.
Брегель ЛВ, Субботин ВМ, Солдатова ТА, Л.В., Белозеров Ю.М., Бойко Т.В., Голенецкая Е.С. Эпидемиологические особенности болезни Кавасаки в Иркутской области. Результаты многолетних наблюдений. Педиатрия 2011; т.90;№5:49-53
Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006 Jul;65(7):936-941
Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013) Digest version. JCS Joint Working Group Circ J. 2014;78(10):2521-62
Лыскина Г.А., Виноградова О.И., Ширинская О.Г., Брегель Л.В., Субботин В.М., Бернс Д. Клиника, диагностика и лечение синдрома Кавасаки. Клинические рекомендации. Всероссийская общественная организация Ассоциация детских кардиологов России. М. 2011:57с. (доступно по ссылке: http://www.cardio rus.ru/doc/kawasaki.pdf )
Baker A.L.; Lu M.; Minich L .L. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009; 154(4):592-595
Valentini P; Ausili E; Schiavino A et al. Acute cholestasis: atypical onset of Kawasaki disease.Dig Liver Dis. 2008; 40(7):582-4
Zulian F; Falcini F; Zancan L. et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr. 2003; 142(6):731-5
Kato H1, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;15;94(6):1379-1385.
Rowley AH, Gonzalez CF, Giding SS,et al. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110 :409-13
Papadodima SA; Sakelliadis EI; Goutas ND; et al. Atypical kawasaki disease presenting with symptoms from the genitourinary system: an autopsy report. J. Trop Pediatr. 2009; 55(1):55-7
Sasaki T(1), Miyata R, Hatai Y. et al. Hounsfield unit values of retropharyngeal abscess-like lesions seen in Kawasaki disease. Acta Otolaryngol. 2014;134(4):437-40.
American Heart Association, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990; 144:1218-9
Ritei Uehara, Yosikazu Nakamura, Hirochi Yanagawa Epidemiology of Kawasaki disease in Japan JMAJ 2005 48(4):183-193
Newburger J.W., Takahashi M., Gerber M.A. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114: 1708-1733.
Ogata S.. BandoY., Kimura S. et al. The strategy of additional immune globulin and steroid pulse therapy. J. Cardiol. 2009; 53: 15-19.
http://www.uptodate.com
Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, et al. Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol. Jul 2005;25(4):309-13
Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulinresistant Kawasaki disease. J Pediatr. 2008;153(6):833-8.
Accomando S, Liotta A, Maggio MC et al. Infliximab administration effective in the treatment of refractory Kawasaki disease. Pediatr Allergy Immunol. 2010; 21(7):1091
Suzuki H, Terai M, Hamada H, et al. Cyclosporin A treatment for kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J 2011; 30(10):871-6.
Tremoulet AH, Pancoast P, Franco A, et al. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012 Sep;161(3):506-512
D Eleftheriou, M Levin, D Shingadia, R Tulloh, NJ Klein, PA Brogan Management of Kawasaki disease. Arch Dis Child. 2014 Jan; 99(1): 74–83.
Kawasaki syndrome. In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.413
Linnemann CC Jr, Shea L, Partin JC, et al. Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol 1975; 101:517.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница